当前位置: X-MOL 学术Clin. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cost-effectiveness and Cost-utility of the Adherence Improving Self-management Strategy in Human Immunodeficiency Virus Care: A Trial-based Economic Evaluation
Clinical Infectious Diseases ( IF 8.2 ) Pub Date : 2018-09-14 , DOI: 10.1093/cid/ciy553
Ben F M Wijnen 1, 2 , Edwin J M Oberjé 3, 4 , Silvia M A A Evers 1, 2 , Jan M Prins 5 , Hans-Erik Nobel 5 , Cees van Nieuwkoop 6 , Jan Veenstra 7 , Frank J Pijnappel 5 , Frank P Kroon 8 , Laura van Zonneveld 9 , Astrid G W van Hulzen 10 , Marjolein van Broekhuizen 11 , Marijn de Bruin 12
Affiliation  

Several promising human immunodeficiency virus (HIV) treatment adherence interventions have been identified, but data about their cost-effectiveness are lacking. This study examines the trial-based cost-effectiveness and cost-utility of the proven-effective Adherence Improving Self-Management Strategy (AIMS), from a societal perspective, with a 15-month time horizon.

中文翻译:

在人类免疫缺陷病毒护理中坚持自我改善策略的成本效益和成本效用:基于试验的经济评估

已经确定了几种有前途的人类免疫缺陷病毒(HIV)治疗依从性干预措施,但缺乏有关其成本效益的数据。这项研究从社会的角度,以15个月的时间跨度,考察了行之有效的坚持自我改进自我管理策略(AIMS)的基于试验的成本效益和成本效用。
更新日期:2018-09-14
down
wechat
bug